R&D Division, Biologics Research Laboratories, Daiichisankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan.
Appl Microbiol Biotechnol. 2013 Mar;97(6):2531-9. doi: 10.1007/s00253-012-4365-9. Epub 2012 Aug 29.
Secretory capacities including folding and assembly are believed to be limiting factors in the establishment of mammalian cell lines producing high levels of recombinant therapeutic proteins. To achieve industrial success, it is also important to improve protein folding, assembly, and secretory processes in combination with increasing transcription and translation. Here, we identified the expression of CHOP/Gadd153 and GRP78, which are unfolded protein response (UPR)-related genes, correlated with recombinant antibody production in stable CHO cells. Subsequently, CHOP overexpression resulted in increasing recombinant antibody production in some mammalian cell lines, and in addition a threefold further enhancement was obtained by combining expression with UPR-related genes or ER chaperones in transient assays. Overexpression of CHOP had no effect on the biochemical characteristics of the product. These results suggest overexpression of CHOP and its combinations may be an effective method to efficiently select a single cell line with a high level of antibody production in the development of cell lines for manufacturing.
分泌能力,包括折叠和组装,被认为是在建立生产高水平重组治疗蛋白的哺乳动物细胞系方面的限制因素。为了取得工业上的成功,还必须结合增加转录和翻译来改善蛋白质折叠、组装和分泌过程。在这里,我们鉴定了与稳定 CHO 细胞中重组抗体生产相关的未折叠蛋白反应 (UPR) 相关基因 CHOP/Gadd153 和 GRP78 的表达。随后,CHOP 的过表达导致一些哺乳动物细胞系中重组抗体产量的增加,并且在瞬时测定中与 UPR 相关基因或 ER 伴侣蛋白的表达相结合还获得了三倍的进一步增强。CHOP 的过表达对产物的生化特性没有影响。这些结果表明,CHOP 的过表达及其组合可能是一种有效的方法,可用于在用于制造的细胞系开发中高效选择具有高水平抗体产生的单个细胞系。